193 related articles for article (PubMed ID: 36335454)
1. Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway.
Li W; Yang W; Yang C
Allergol Immunopathol (Madr); 2022; 50(6):115-121. PubMed ID: 36335454
[TBL] [Abstract][Full Text] [Related]
2.
Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
[TBL] [Abstract][Full Text] [Related]
3. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.
Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J
Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod induced ApoE-deficient mice might be a composite animal model for the study of psoriasis and dyslipideamia comorbidity.
Xie X; Zhang L; Lin Y; Wang Y; Liu W; Li X; Li P
J Dermatol Sci; 2017 Oct; 88(1):20-28. PubMed ID: 28579438
[TBL] [Abstract][Full Text] [Related]
5. Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balance.
Shahine Y; El-Aal SAA; Reda AM; Sheta E; Atia NM; Abdallah OY; Ibrahim SSA
Inflammopharmacology; 2023 Jun; 31(3):1341-1359. PubMed ID: 37010718
[TBL] [Abstract][Full Text] [Related]
6. Elevated cholesteryl ester transfer and phospholipid transfer proteins aggravated psoriasis in imiquimod-induced mouse models.
Chen J; Qi H; Liu L; Niu Y; Yu S; Qin S; He L
Lipids Health Dis; 2022 Aug; 21(1):75. PubMed ID: 35982498
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Compound K Reduces Psoriasis-related Inflammation by Activation of the Glucocorticoid Receptor in Keratinocytes.
Wang W; Xu X; Yang M; Jiang M; Wang D; Tang C; Wei W; Chen J
Curr Mol Pharmacol; 2024 Feb; 17():e18761429254358. PubMed ID: 38389423
[TBL] [Abstract][Full Text] [Related]
8. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
[TBL] [Abstract][Full Text] [Related]
9. DPP-4 inhibitor linagliptin ameliorates imiquimod-induced psoriasis-like skin alterations in type 2 diabetic mice by inhibiting the MAPK/NF-κB inflammatory pathway.
Shao Z; Li X; Xu X; Chen P
Drug Dev Res; 2022 Sep; 83(6):1373-1382. PubMed ID: 35749612
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
[TBL] [Abstract][Full Text] [Related]
11. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
12. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice].
Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P
Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945
[TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
14. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
[TBL] [Abstract][Full Text] [Related]
16. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
Shi Q; He Q; Chen W; Long J; Zhang B
J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
[TBL] [Abstract][Full Text] [Related]
18. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
[TBL] [Abstract][Full Text] [Related]
19. Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity
Xie X; Zhang L; Li X; Liu W; Wang P; Lin Y; Han X; Li P
Front Pharmacol; 2021; 12():591608. PubMed ID: 33762935
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of punicalagin attenuates imiquimod-induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF-κB signaling pathways.
Wang Y; Han D; Huang Y; Dai Y; Wang Y; Liu M; Wang N; Yin T; Du W; He K; Zheng Y
Phytother Res; 2024 Feb; 38(2):713-726. PubMed ID: 38009260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
